Engineers Gate Manager LP Aerie Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$4.95 - $9.16 $106,920 - $197,856
21,600 New
21,600 $162,000
Q1 2022

May 16, 2022
SELL
$5.64 - $9.8 $493,618 - $857,705
-87,521 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.02 - $13.33 $614,397 - $1.17 Million
87,521 New
87,521 $614,000
Q2 2021

Aug 16, 2021
SELL
$15.16 - $18.97 $217,394 - $272,029
-14,340 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$13.12 - $20.9 $188,140 - $299,706
14,340 New
14,340 $256,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email